Agarwal Garima S, Agrawal Anil K
Pathology, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education & Research, Wardha, IND.
Cureus. 2024 Sep 30;16(9):e70529. doi: 10.7759/cureus.70529. eCollection 2024 Sep.
Background Pregnancy-induced hypertension (PIH) is a major cause of maternal and fetal morbidity and mortality. PIH, including gestational hypertension, pre-eclampsia, and eclampsia, often leads to significant alterations in coagulation profiles and haematological parameters, posing risks for thromboembolic and haemorrhagic complications. This study aimed to compare the coagulation and haematological parameters between women with PIH and normotensive pregnant women. Methods A cross-sectional observational study was conducted on 110 pregnant women, divided into two groups: 55 with PIH and 55 with normotensives. Coagulation markers such as prothrombin time (PT), activated partial thromboplastin time (aPTT), international normalised ratio (INR), and platelet count were measured. Bleeding and clotting times were also evaluated. Data were statistically analysed using student's t-test and chi-square tests, with p ≤ 0.05 considered significant. Results Women with PIH exhibited significantly lower platelet counts, PT, aPTT, and INR values compared to the normotensive group (p < 0.0001). Thrombocytopenia and prolonged bleeding time were more common in the PIH group, suggesting an increased risk of both bleeding and clotting complications. Proteinuria was observed in 32 women (58.18%) in the PIH group, reflecting the severity of the disease. Additionally, the PIH group had markedly elevated blood pressure levels. Conclusion PIH is associated with significant coagulation and haematological abnormalities, including thrombocytopenia and a hypercoagulable state, which increase the risk of thromboembolic and hemorrhagic events. Routine monitoring of coagulation profiles and haematological parameters in PIH patients is essential for timely interventions and improving maternal and fetal outcomes.
妊娠高血压疾病(PIH)是孕产妇和胎儿发病及死亡的主要原因。PIH包括妊娠期高血压、子痫前期和子痫,常导致凝血指标和血液学参数发生显著变化,带来血栓栓塞和出血并发症的风险。本研究旨在比较PIH孕妇与血压正常的孕妇之间的凝血和血液学参数。
对110名孕妇进行了一项横断面观察性研究,分为两组:55名PIH孕妇和55名血压正常的孕妇。测量了凝血指标,如凝血酶原时间(PT)、活化部分凝血活酶时间(aPTT)、国际标准化比值(INR)和血小板计数。还评估了出血和凝血时间。数据采用学生t检验和卡方检验进行统计学分析,p≤0.05被认为具有统计学意义。
与血压正常组相比,PIH孕妇的血小板计数、PT、aPTT和INR值显著降低(p<0.0001)。血小板减少症和出血时间延长在PIH组更为常见,提示出血和凝血并发症的风险增加。PIH组有32名妇女(58.18%)出现蛋白尿,反映了疾病的严重程度。此外,PIH组的血压水平明显升高。
PIH与显著的凝血和血液学异常有关,包括血小板减少症和高凝状态,这增加了血栓栓塞和出血事件的风险。对PIH患者进行凝血指标和血液学参数的常规监测对于及时干预和改善母婴结局至关重要。